In many cancer types, it is known to aid in tumour progression (HIV-positive cervical cancer [67]), while in gastric adenocarcinoma [68] and prostate cancer [69] cases, diminished levels of IL-10 are found to be a high-risk factor. This evidence concerns the gene IL10 and neoplasm.